This is in agreement with previous findings showing that the mesenchymal-like breast cancer stem cells are characterized as CD24−/CD44+, while the epithelial-like breast cancer stem cells express high levels of aldehyde dehydrogenase (ALDH) [16]. The gene discussed is CD24; the disease is breast carcinoma.